Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement profile in primary biliary cirrhosis.

M Schlesinger1, C Benbassat, Y Shoenfeld

  • 1Clinical Immunology Unit, Barzilai Medical Center, Ashkelon, Israel.

Immunologic Research
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parathyroid adenoma: a comprehensive biochemical and histological correlative study.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2016
Same author

Expression of CD11a (LFA-1) on B-chronic Lymphocytic Leukemia and Lymphoma Cells: Correlation with Cell Surface Immunoglobulin Intensity and CD58 (LFA-3) Expression.

Leukemia & lymphoma·2016
Same author

MRI contrast agent concentration and tumor interstitial fluid pressure.

Journal of theoretical biology·2016
Same author

Helicobacter pylori infection in patients with selective immunoglobulin a deficiency.

Clinical and experimental immunology·2016
Same author

Quantum-classical transition and quantum activation of ratchet currents in the parameter space.

Physical review. E, Statistical, nonlinear, and soft matter physics·2015
Same author

Interstitial hydraulic conductivity and interstitial fluid pressure for avascular or poorly vascularized tumors.

Journal of theoretical biology·2015
Same journal

Emapalumab plus conventional therapy with or without ruxolitinib for pediatric hemophagocytic lymphohistiocytosis: a single center retrospective study.

Immunologic research·2026
Same journal

Immunological spectrum in patients with thymoma: beyond good syndrome.

Immunologic research·2026
Same journal

Microbiome immune crosstalk in Sjögren's syndrome: mechanistic insights and translational perspectives.

Immunologic research·2026
Same journal

Immune checkpoint inhibitor-induced myasthenia gravis and myocarditis: a fatal immune-related adverse event.

Immunologic research·2026
Same journal

TRIM28 and TRIM32: multifaceted regulators of innate immunity and antiviral defence.

Immunologic research·2026
Same journal

Decoding PANoptosis: Crosstalk of cell death pathways in immunity and inflammation.

Immunologic research·2026
See all related articles

Primary biliary cholangitis (PBC) patients show elevated levels of most serum complement components, suggesting a role for the complement system in this autoimmune liver disease. Further research is needed to understand these alterations.

Area of Science:

  • Immunology
  • Hepatology
  • Autoimmune Diseases

Background:

  • Primary biliary cholangitis (PBC) is a chronic, progressive autoimmune liver disease.
  • The relationship between autoimmune disorders and the complement system is complex, yet understudied in PBC.
  • Previous studies on serum complement levels in PBC are limited in patient numbers and scope.

Purpose of the Study:

  • To investigate the levels of 10 serum complement components in patients with PBC.
  • To compare these levels with those of healthy controls.
  • To explore the potential role of complement system alterations in PBC pathogenesis.

Main Methods:

  • Serum samples from 73 PBC patients were analyzed.
  • Levels of 10 specific complement components (C1q, C2, C3, C4, C5, C6, C7, C8, properdin, factor B) were measured.

Related Experiment Videos

  • Statistical comparison with healthy control groups was performed.
  • Main Results:

    • Significant elevations were observed in C1q, C2, C3, C5, C7, properdin, and factor B levels in PBC patients.
    • C4 levels were slightly lower in PBC patients compared to controls (p = 0.019).
    • C6 and C8 levels were within the normal range, though a higher proportion of PBC patients had low C4 and C6 levels, this was not statistically significant.

    Conclusions:

    • The study demonstrates significant alterations in the levels of most serum complement components in PBC patients.
    • These findings support the hypothesis of PBC being an autoimmune disease with complement system involvement.
    • The precise mechanisms driving these complement alterations in PBC require further investigation.